This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Aprepitant Accord 80 mg hard capsules PA2315/148/001 Accord Healthcare Ireland Ltd. | Aprepitant |
| Dipentum 250mg hard Capsules PA22657/001/001 Atnahs Pharma Netherlands B.V. | Olsalazine sodium |
| Dipentum 500mg hard Capsules PA22657/001/002 Atnahs Pharma Netherlands B.V. | Olsalazine sodium |
| GENOTROPIN 5.3 mg powder and solvent for solution for injection, with preservative PA0822/128/001 Pfizer Healthcare Ireland | Somatropin |
| Imuger 25 mg Film-coated Tablets PA0577/032/001 McDermott Laboratories Ltd., T/A Gerard Laboratories | Azathioprine |
| Klacid Paediatric Suspension 125mg/5ml, Granules for Oral Suspension PA23355/013/005 Viatris Healthcare Limited | Clarithromycin |
| Palmeux 75 mg prolonged-release suspension for injection in pre-filled syringe PA1142/040/003 Amdipharm Limited | Paliperidone |
| Renvela 0.8 g powder for oral suspension EU/1/09/521/008 Genzyme Europe B.V. | Sevelamer |
| Tamoxifen 20 mg Tablets PA0577/207/001 Mc Dermott Labratories | Tamoxifen |
| Ultiva 1 mg Powder for Concentrate for Solution for Infusion PA1691/032/001 Aspen Pharma Trading Limited | Remifentanil |
| Ultiva 2 mg Powder for Concentrate for Solution for Infusion PA1691/032/002 Aspen Pharma Trading Limited | Remifentanil |
| Xylocaine 2% with Adrenaline PA1691/027/001 Aspen Pharma Trading Limited | Adrenaline & Lidocaine |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Carboplatin-Teva 10 mg/ml Concentrate for Solution for Infusion(50mg/5ml presentation) PA0749/004/001 Teva Pharma B.V. | Carboplatin |
| Chloromycetin 0.5% w/v Redidrops eye drops, solution PA1142/021/001 Amdipharm Limited | Chloramphenicol |
| CHOLESTAGEL 625 mg FILM-COATED tablets EU/1/03/268/1-3 CHEPLAPHARM Arzneimittel GmbH | Colesevelam |
| CitraFleet, Powder for oral solution in sachet PA2028/002/001 Casen-Recordati S.L | Sodium picosulfate & Light magnesium oxide & Citric acid |
| Creon for Children 5000 Gastro-resistant Granules PA23355/006/003 Viatris Healthcare Limited | Lipase & Amylase & Protease |
| Evorel 50 micrograms per 24 hours Transdermal Patch PA22668/008/001 Theramex Ireland Limited | Estradiol |
| Heparin Sodium 10 I.U./ml flushing solution for maintenance of patency of intravenous devices PA0281/230/001 Pinewood Laboratories Ltd | Heparin sodium |
| Monopost Unidose 50 micrograms/ml eye drops, solution in single-dose container PA1107/007/001 Laboratoires Thea | Latanoprost |
| NovoSeven (400 KIU) 2mg EU/1/96/006/007 Novo Nordisk A/S | Eptacog alfa (activated) |
| Tobi Podhaler EU/1/10/652/001-003 Viatris Limited | Tobramycin |
| Ondansetron 2 mg/ml Solution for Injection or Infusion PA0577/083/001 McDermott Laboratories Ltd., T/A Gerard Laboratories | Ondansetron |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.